In this study, we focused on two pathways, (1) PI3K/AKT and (2) Raf/MEK/ERK, which both play a vital role in glioma cell fate and are aberrant in the miR-21 and/or CXCR4 overexpression environment [11, 30–34]. The gene discussed is AKT1; the disease is glioma.